biocon q4 earnings: Biocon Q4 Results: Cons PAT grows 31% YoY to Rs 313 crore, revenue surges 57%
MUMBAI – Pharmaceutical major Biocon today reported a 31.3% year-on-year (YoY) rise in consolidated net profit for the March quarter to Rs 313 crore on the back of a strong …
biocon q4 earnings: Biocon Q4 Results: Cons PAT grows 31% YoY to Rs 313 crore, revenue surges 57% Read More